Scientific Program


28 August 2019   29 August 2019  30 August 2019  31 August 2019  1 September 2019


 

Session 10

Wednesday, 28 August 2019

Special Session: Latest Research from China

9:00 am - 1:00 pm

Part 1: Animal and zoonotic influenza in China

Part 2: Pharmaceutical research in China (with a focus on Chinese medicine)

3:00 pm - 3:30 pm 

WELCOME

3:30 pm - 4:00 pm 

Coffee Break in the Exhibit Hall

4:00 pm - 5:30 pm 

Opening Keynotes

Pandemic/Avian Flu through the years/risk to the future

Current state of science/future development

Impact of Influenza/Pandemics - what can be done for the future?

Welcome Reception in the Exhibit Hall

5:30 pm - 6:30 pm

 

Thursday, 29 August 2019

8:30am - 10:00am

Plenary Session 1 - Vaccines

10:00am- 10:30am Coffee Break in the Exhibit Hall
10:30am-12:30pm

SESSION 1

Virus Pathogenesis & Transmission Diagnosis I Vaccine Efficacy / Effectiveness I
1. Transmission of avian influenza viruses 1.  Point-of-care tests [eg. clinical utility, cost-effectiveness, limitations]                      1. Attenuation of Disease
 2. Pathogenesis and transmission of emerging influenza viruses 2 Host response signatures and transcriptomics 2. VE Against Alternative Endpoints
3. Determinants of influenza virus transmission 3 Biomarkers including Procalcitonin, CRP 3 Impact on cardiovascular outcomes
Oral Presentations (6) Oral Presentations (6) Oral Presentations (6)
12:30pm - 2:00pm

Lunch Break in Exhibit Hall / Sponsored Lunch Symposia

2:00pm - 4:00pm

SESSION 2

Diagnosis II Vaccine Efficacy/Effectiveness II Co-infection
1 Antiviral resistance [NAIs] 1 2019 Southen Hemisphere Vaccine Efficacy 1 Vaccination against viral infections to reduce antimicrobial resistance
2 Antiviral resistance [Polymerase inhibitors] 2 Immune responses to repeated vaccination 2 Interactions between influenza and pneumococci
3 Clinical studies on immunopathogenesis 3 VE after repeated vaccination 3 Influenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms
Oral Presentations (6) Oral Presentations (6) Oral Presentations (6)
4:00 pm - 4:30 pm    Coffee Break in the Exhibit Hall
4:30pm - 6:00pm

SESSION 3

Influenza Glycobiology Treatment I Surveillance & Forecasting
1 Investigating virus-glycan interactions using novel glycan arrays 1 The ‘polymerase inhibitors’ [clinical data]

1 Forecasting activity

2 Glycan specificity of hemagglutinins 2 Serotherapy [clinical data: immune plasma, hyperimmune IVIG, monocloncals] 2 Forecasting epidemics
3 Role of antibody glycans in influenza immunity 3 Antiviral resistance, management aspects [esp. in immunosuppressed hosts] 3 Forecasting virus strains
Oral Presentations (4) Oral Presentations (4) Oral Presentations (4)
6:00pm  - 7:30pm

Poster Session 1

 

Friday, 30 August 2019

8:30 am – 10:00 am 

Plenary Session 2: PISA & Virology

10:00am – 10:30am Coffee Break in the Exhibit Hall
10:30am - 12:30pm

Session 4

NextGen/Universal Vaccines Treatment II Optimising Vaccine Strategies I

1 Neuraminidase vaccines

1 Adjuvant therapy [overview; macrolides, statins]

1 Immune responses to enhanced vaccines (Rochester)

2 Computationally optimized broadly reactive antigen (COBRA) vaccines 2 Corticosteroids 2 Immune responses to enhanced vaccines/combinations (PIVOT)
3 T cell antigen vaccines 3 Vaccine Hesistancy 3 Efficacy of liver-attenuated vaccines
Oral Presentations (6) Oral Presentations (6) Oral Presentations (6)
12:30pm - 2:00pm

Lunch Break in Exhibit Hall / Sponsored Lunch Symposia

2:00pm - 4:00pm

SESSION 5

Immune Response to Infection Optimising Vaccine Strategies II Controlled Human Infection Model (CHIM) Challenge Studies

1 T cell responses to influenza infection in humans

1.Childhood Program

1 Human challenge with LAIV

2 Determinants of immune response to influenza, healing, pathology, and memory 2 Communication 2. Infection biomarker assisted decision-making for infectioius disease
3 - Immune responses to zoonotic influenza viruses in animal models   3. Learning human immunology from live viral challenge of volunteers
    4. Human Challenge
Oral Presentations (6) Oral Presentations (7) Oral Presentations (5)
4:00 pm - 4:30 pm Coffee Break in the Exhibit Hall
4:30pm - 6:00pm

SESSION 6

Cellular and Molecular Virology Avian and Zoonotic Influenza Pandemic Preparedness

1 Regulation of virus replication

1 Clinical features of Avian influenza [H7N9]

1 Pandemic Risk Assessment

2 Influenza Viral RNA Assembly 2 Swine virus infections 2 Vaccine Preparedness - BARDA
3 Viral mini RNAs 3 Clinical features of H5N1 and other NA subtypes 3 Testing Pre-Pandemic Vaccines - NIH VTU
4 Modulation of cellular sphingolipids during influenza infection     
Oral Presentations (3) Oral Presentations (4) Oral Presentations (4)
6:00pm  - 7:30pm

Poster Session 2

   

Saturday, 31 August 2019

8:30am - 10:00am

Plenary Session 3 - Burden of Disease

10:00am - 10:30am Coffee Break in the Exhibit Hall
10:30am - 12:30pm

Session 7

Host-Pathogen Interactions Influenza in the Tropics Policy Perspectives for the Prevention and Control lof Seasonal Influenza

1 Immunity to influenza in dirty mice

1 Flu in tropics

1 Effectiveness of influenza vaccination in different populations

2 Obesity as a risk factor in influenza virus infection 2 Seasonality or Waning of Protection 2 Effectiveness of neuraminidase inhibitor treatment/effectiveness of antivirals
3 Viral determinants of pathogenisis 3 Timing of vaccination 3 Policy considerations for the prevention and control of seasonal influenza - High Income Country
Oral Presentations (4) Oral Presentations (4) 4 Policy considerations for the prevention and control of seasonal influenza - Middle Income Country
    5 Panel discussion on overcoming challenges for implementation of prevention and control of seasonal influenza - Low Income country
12:30pm - 2:00pm

Lunch Break in Exhibit Hall / Sponsored Lunch Symposia

2:00pm - 3:30pm

SESSION 8

Antivirals Special Populations - Clinical Aspects Policy Perspectives for Pandemic Influenza Preparedness & Response

1 Antiviral resistance - do we need to worry?

1 Pediatrics [e.g. mortality, neurologic complications, antiviral use]

1: Evidence on effectiveness of non-pharmaceutical measures

2 Inhibitors targeting the Rdp 2 Pregnant women 2: Policy considerations for pandemic preparedness and response planning - High Income country
3 Structure-based design of novel inhibitors 3 Elderly, including vaccination 3: Policy considerations for pandemic preparedness and response planning -  Middle Income country
Oral Presentations (4) Oral Presentations (4) Panel discussion on overcoming challenges for pandemic preparedness planning
3:30 pm - 4:00 pm Coffee Break in the Exhibit Hall
4:00pm - 5:30pm

SESSION 9

Influenza Evolution & Human Ecology Critical Influenza Illness Disease burden, Impact and Severity

1 Experimental and computational approaches to understanding influenza evolution

1 The critically ill [e.g. management, ECMO]

 

2 Emergence and evolution of zoonotic influenza viruses 2 Cardiovascular complications (eg, MI, myocarditis, stroke) 2.Global hospitalization burden
3 Evolution of seasonal influenza viruses 3 Neurological complications  
Oral Presentations (4) Oral Presentations (4) Oral Presentations (4)
5:30pm - 7:00pm

Poster Session 3

Conference Gala Dinner at the Flower Dome - Gardens by the Bay (ticketed event)

Sunday, 1 September 2019

8:30am - 10:30am

Session 10

Non-Human Influenza Viruses Regional Respiratory Infection Surveillance Systems Imprinting, Sero-epidemiology, Age Profile Differences

1 Swine influenza

1 European experience

1: Epidemiologic signs of imprinting

2 Canine influenza 2 APARIS rep 2: Mechanisms for imprinting
3 Avian influenza Country experience 3: Sero-epidemiology
Oral Presentations (6) Oral Presentations (6) Oral Presentations (6)
10:30am - 11:00am

Coffee Break in Exhibit Hall

11:00am - 1:00pm

SESSION 11

Emerging Influenza Viruses Vaccines Epidemiology and Transmission

1 Zoonotic influenza/ One health

1 Immune imprinting

1 Someone on hospital outbreaks 

2 Emergence of swine influenza in Australia 2 Vaccination Immunocompromised 2 Deep sequencing and mapping chains of transmission
3 Emergence of avian influenza viruses 3 Optimal approach to vaccinating the elderly 3 Transmission
4 Bat influenza viruses    
Oral Presentations (5) Oral Presentations (6) Oral Presentations (6)
1:00pm - 1:30pm Refreshment Break
1:30pm +

Closing Plenary Session